C07D 211/40
Oxygen atoms
C07D211/40 (Oxygen atoms) appears on 2,033 US grants and 1,613 published applications in this corpus.
Search patents in C07D- Granted patents
- 2,033
- Published applications
- 1,613
- Assignees
- 851
- Inventors
- 5,719
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 35 | 0 |
| 1977 | 46 | 0 |
| 1978 | 50 | 0 |
| 1979 | 28 | 0 |
| 1980 | 37 | 0 |
| 1981 | 38 | 0 |
| 1982 | 40 | 0 |
| 1983 | 38 | 0 |
| 1984 | 22 | 0 |
| 1985 | 39 | 0 |
| 1986 | 22 | 0 |
| 1987 | 19 | 0 |
| 1988 | 25 | 0 |
| 1989 | 26 | 0 |
| 1990 | 27 | 0 |
| 1991 | 27 | 0 |
| 1992 | 27 | 0 |
| 1993 | 44 | 0 |
| 1994 | 29 | 0 |
| 1995 | 35 | 0 |
| 1996 | 33 | 0 |
| 1997 | 46 | 0 |
| 1998 | 35 | 0 |
| 1999 | 42 | 0 |
| 2000 | 33 | 0 |
| 2001 | 35 | 11 |
| 2002 | 63 | 64 |
| 2003 | 57 | 86 |
| 2004 | 39 | 91 |
| 2005 | 57 | 90 |
| 2006 | 45 | 100 |
| 2007 | 42 | 90 |
| 2008 | 39 | 74 |
| 2009 | 74 | 92 |
| 2010 | 63 | 79 |
| 2011 | 55 | 73 |
| 2012 | 53 | 63 |
| 2013 | 67 | 55 |
| 2014 | 46 | 61 |
| 2015 | 61 | 59 |
| 2016 | 42 | 60 |
| 2017 | 59 | 60 |
| 2018 | 36 | 61 |
| 2019 | 47 | 48 |
| 2020 | 45 | 36 |
| 2021 | 38 | 43 |
| 2022 | 30 | 53 |
| 2023 | 28 | 54 |
| 2024 | 25 | 41 |
| 2025 | 27 | 46 |
| 2026 | 17 | 23 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- P38alpha mitogen-activated protein kinase inhibitors6 Oct 2026US 12,753,184 B2Gen1E Lifesciences Inc.
- Ferroptosis inhibitors—diarylamine para-acetamides25 Aug 2026US 12,715,855 B2Sironax Ltd.
- Transcriptional enhanced associate domain (TEAD) transcription factor inhibitors and uses thereof4 Aug 2026US 12,698,259 B2Dana-Farber Cancer Institute, Inc.
- Methods for separation and recovery of rare earth elements from aqueous solutions using diglycolamide derivatives30 Jun 2026US 12,668,857 B2Battelle Energy Alliance, LLC
- Solid state forms of lucerastat and process for preparation thereof23 Jun 2026US 12,662,452 B2Assia Chemical Industries Ltd.
- Cobalt-catalyzed carbonylative alkene hydrofunctionalizations promoted by visible light8 Oct 2026US 2026/0308103 A1
- Flame retardant, composition, and molded article1 Oct 2026US 2026/0297296 A1Adeka Corporation
- Heterocycloalkyl beta-hydroxy alkyl amines for use in the treatment of hyperglycaemia and disorders characterised by hyperglycaemia20 Aug 2026US 2026/0242335 A1Atrogi AB
- Amyloid targeting agents30 Jul 2026US 2026/0217667 A1Amydis, Inc.
- 1-deoxynojirimycin derivative and use thereof23 Jul 2026US 2026/0209177 A1Zhejiang University
Most cited
By later US patents
- Antidiabetic 3,4,5-trihydroxypiperidines252US 4,639,436 ABayer Aktiengesellschaft · 1987
- Cyclic amine compounds with activity against acetylcholinesterase174US 4,895,841 AEisai Co., Ltd. · 1990
- Sigma receptor ligands and the use thereof150US 6,057,371 AVirginia Commonwealth University · 2000
- Muscarinic receptor antagonists138US 6,693,202 B1Theravance, Inc. · 2004
- Urea derivatives and their use as ACAT inhibitors134US 5,621,010 ANisshin Flour Milling Co., Ltd. · 1997